ADVERTISEMENT



HEALTHCARE

Kuwait Health Minister refers children demise to prosecution

September 16, 2019

Kuwait Health Minister refers children demise to prosecution

Minister of Health Dr. Bassel Al­Sabah has referred two cases concerning death of a male child at a dentistry center and two children at a hospital to public prosecution.

The Ministry of Health (MoH) said in a statement on Sunday that the minister had also barred officials related to the cases from travelling or working in"... Continue Reading

MoH responds to NDMA reports

September 15, 2019

MoH responds to NDMA reports

KUWAIT: Responding to FDA and EMA warnings that some ranitidine antacid and antihistamine drugs, including Zantac, include the carcinogenic impurity N-nitrosodimethylamine (NDMA), the health ministry’s assistant undersecretary for food and medical control Dr Abdullah Al-Bader said special preventive measures will be taken including withdrawing samples of these medications for further analysis in collaboration"... Continue Reading

Proposal rejected to float tender for ‘79 ambulances’

September 12, 2019

Proposal rejected to float tender for ‘79 ambulances’

KUWAIT CITY, Sept 11: In a recent meeting, health sources disclosed that the Central Agency for Public Tenders (CAPT) had turned down the ministry’s proposal to float a tender to supply 79 ambulances, because the related documents were not in line with tender law no. 49/2016, and CAPT is waiting for a representative from the ministry to explain some items before presenting the proposal to the oversight"... Continue Reading

Health problems in grade 10 students

September 12, 2019

Health problems in grade 10 students

KUWAIT CITY, Sept 11: The Ministry of Health has conducted a national survey to determine the rate of health problems such as high blood pressure, diabetes and blood fats among grade 10 students in public and private schools, reports Al-Jarida daily.

The ministry distributed questionnaires to the schools where grade 10 students"... Continue Reading

Kuwait Health Ministry to set up medical accountability board

September 11, 2019

Kuwait Health Ministry to set up medical accountability board

Kuwait’s Health Ministry plans to introduce a department tasked with the medical accountability of public and private healthcare practices, Minister Sheikh Basel Humoud Al-Sabah revealed on Monday.

Based on a ministerial decree, the body of three sectors will recieve claims into alleged errors, review the accuracy of these"... Continue Reading

Fakih IVF Extends Support to All Women Battling PCOS

September 11, 2019

Fakih IVF Extends Support to All Women Battling PCOS

Polycystic Ovarian Syndrome (PCOS) is among the most common causes of infertility among women in the UAE. In order to address this issue, during the ‘PCOS Awareness Month’ in September, Fakih IVF is looking to reach out to all women by providing them with services that would educate them more on the subject.

PCOS is"... Continue Reading

Ministry suspends air ambulances service due to contract expiration

September 10, 2019

Ministry suspends air ambulances service due to contract expiration

KUWAIT CITY, Sept 9: Director of the Medical Emergency Department in the Ministry of Health Mundhir Al-Jalahima has affirmed the suspension of air ambulance service due to the expiration of the contract signed by the ministry and the operating company in 2014.

In a press statement, Al-Jalahima said there is no alternative to the"... Continue Reading

Samsung Bioepis Continues Global Expansion, Enters Brazilian Biopharmaceutical Market with BRENZYS™ (etanercept)

September 10, 2019

Samsung Bioepis Continues Global Expansion, Enters Brazilian Biopharmaceutical Market with BRENZYS™ (etanercept)

Samsung Bioepis Co., Ltd. today announced its expansion into the Brazilian biopharmaceutical market. The first product available in the country is BRENZYS™ (etanercept), a biosimilar referencing ENBREL®.i BRENZYS™ was approved by Agência Nacional de Vigilância Sanitária (ANVISA), the country’s health regulatory agency, in December 2017 for the treatment of rheumatoid"... Continue Reading

Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA

September 9, 2019

Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that it has initiated investigational new drug (IND)-enabling studies for ALS-4, a small drug molecule candidate indicated for the treatment of infections caused by Staphylococcus aureus (or “S. aureus”)"... Continue Reading

Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma

September 9, 2019

Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the development of two preclinical drug candidates which target obesity and neuroblastoma, respectively.

About CLS-1: Treatment of obesity"... Continue Reading

Found articles: - Pages